​Department of Gastroenterology and Gastrointestinal Surgery, Hvidovre Hospital has since the 1970's taken a leadership position in research, development, education, and treatment of acute and chronic pancreatitis. 


  • PACE as the leading center in Denmark with respect to research and treatment of benign pancreatic diseases. 


  • Complicated acute and chronic pancreatitis with special focus on endoscopy and use of minimal invasive techniques
  • Innovative patient-related research with emphasis on an inter-disciplinary approach.
  • National and international cooperation with leading research groups.


The unit's focus is endoscopy, since it is thereby possible with minimally invasive techniques to treat disabling and potentially life-threatening complications of acute and chronic pancreatitis. In 2005, the unit as the first hospital in Denmark adopted endoscopic treatment of severe necritizing pancreatitis. Until then, the only treatment option in this disease had been open surgery with associated high complication and mortality rates, even among otherwise healthy patients of young age. With the endoscopic method, the mortality dropped from average 20% in open surgery to 10%. As a consequence of the unit's achievements, most surgical departments have now abandoned open surgery in these patients. The unit has continuously worked to improve the endoscopic techniques to benefit more patients. Today, the unit has acquired a unique license to treat patients with the most severe forms of acute and chronic pancreatitis from Eastern Denmark, Greenland, and the Faroe Islands. The unit has educated doctors and nurses and has presented its research by lectures and in scientific journals. The unit is part of a Nordic research network investigating endoscopic therapies and has established a national and international collaboration with numerous partners.

The establishment of Pancreatitis Centre East (PACE) is anticipated to strengthen treatment and research of benign pancreatic diseases at Zealand. In addition, PACE will support and consolidate the national and international position of the Capital Region. It is expected that PACE will draw further attention to Hvidovre Hospital, promote and attract young scientists, research fellows, and nurses with special interests in health care of this complicated group of patients. Finally, PACE will facilitate and promote funding and support new initiatives and research programs. 

The University Hospital of Southern Denmark (SDU) has recently launched a center for management of patients with pancreatic diseases (OPAC=Odense PAncreas Center) supported by the Southern Region of Denmark. The primary focus at this centre is malignant pancreatic diseases. Several years ago, Aalborg University Hospital established a pancreatic centre supported by The Northern Region of Denmark. This center also ranges at a very high scientific level with its primary focus on pain due to pancreatic diseases. 

Responsible editor